summit tirzepatide hfpef trial Impact of Obesity Severity on the Effects of in HFpEF: The Obesity-related HFpEF: Tirzepatide benefits appear – SUMMIT: Tirzepatide Reduces Cardiovascular Events

Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis

Once-weekly and once-monthly injectables are pushing the other direction

She adds a GHK-Cucontaining scalp serum once daily at night, massaging it into the frontal hairline and crown for 23 minutes

Avoid the inner arm where veins are more prominent and the skin is thinner